Evidence map›Paper›PMID 33941622›Full record

ArticleScience translational medicine2021

COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters.

Guilherme Dias de Melo, Françoise Lazarini, Sylvain Levallois, Charlotte Hautefort, Vincent Michel, Florence Larrous, Benjamin Verillaud, Caroline Aparicio, Sebastien Wagner, Gilles Gheusi and 11 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Science translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04366934 (Study of the Pathogenesis of Olfactory Disorders in COVID-19), which is not on this map. Cited by 274 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
274citing papers in PubMed, 3 pooled it
54.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04366934 completednot on this map

Study of the Pathogenesis of Olfactory Disorders in COVID-19

TypeobservationalSponsorInstitut PasteurRan2020 to 2020Enrolled26ConditionsCoronavirus Infection, Severe Acute Respiratory Syndrome, Sars-CoV2ArmsNasal swab, Taste and olfactory function evaluation
3 · Its place in the literature

Who cites it

274 citing papers in PubMed, 3 syntheses or guidelines pooled it, 496 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Human brain matters: Navigating the neuropathology of COVID-19.Brain pathology (Zurich, Switzerland) · 2026
    Review
  7. Article
  8. Enhanced detection of respiratory pathogens in olfactory swabs correlates with olfactory dysfunction in chronic rhinosinusitis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

214 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 1 country.

Guilherme Dias de MeloLyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, 75015 Paris, France.ORCID 0000-0003-0747-7760
Françoise LazariniPerception and Memory Unit, Institut Pasteur, CNRS UMR3571, 75015 Paris, France.ORCID 0000-0001-5572-6982
Sylvain LevalloisBiology of Infection Unit, Institut Pasteur, 75015 Paris, France.ORCID 0000-0002-5805-1092
Charlotte HautefortOtolaryngology-Head and Neck Surgery Department, Hopital Lariboisiere, Assistance Publique-Hôpitaux de Paris, INSERM U1141, Université de Paris, 75010 Paris, France.ORCID 0000-0002-5056-5136
Vincent MichelPerception and Memory Unit, Institut Pasteur, CNRS UMR3571, 75015 Paris, France.ORCID 0000-0002-7025-4343
Florence LarrousLyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, 75015 Paris, France.ORCID 0000-0003-0881-4263
Benjamin VerillaudOtolaryngology-Head and Neck Surgery Department, Hopital Lariboisiere, Assistance Publique-Hôpitaux de Paris, INSERM U1141, Université de Paris, 75010 Paris, France.
Caroline AparicioEmergency Department, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010 Paris, France.
Sebastien WagnerPerception and Memory Unit, Institut Pasteur, CNRS UMR3571, 75015 Paris, France.
Gilles GheusiPerception and Memory Unit, Institut Pasteur, CNRS UMR3571, 75015 Paris, France.
Lauriane KergoatLyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, 75015 Paris, France.ORCID 0000-0002-5609-4398
Etienne KornobisPlateforme Technologique Biomics-Centre de Ressources et Recherches Technologiques (C2RT), Institut Pasteur, 75015 Paris, France.ORCID 0000-0001-7712-8270
Flora DonatiNational Reference Center for Respiratory Viruses, Institut Pasteur, 75015 Paris, France.ORCID 0000-0003-2862-9751
Thomas CokelaerPlateforme Technologique Biomics-Centre de Ressources et Recherches Technologiques (C2RT), Institut Pasteur, 75015 Paris, France.ORCID 0000-0001-6286-1138
Rémi HervochonOtolaryngology-Head and Neck Surgery Department, GHU Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, 75013 Paris, France.ORCID 0000-0003-1569-3578
Yoann MadecEmerging Diseases Epidemiology Unit, Institut Pasteur, 75015 Paris, France.ORCID 0000-0002-6201-1261
Emmanuel RozeSorbonne Université, AP-HP, Hôpital de la Pitié-Salpêtrière, Département de Neurologie, INSERM U1127, CNRS UMR 7225, Institut du Cerveau, 75013 Paris, France.ORCID 0000-0001-9727-3459
Dominique SalmonInfectious Diseases and Immunology Department, Cochin Hotel Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75015 Paris, France.
Hervé BourhyLyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, 75015 Paris, France.ORCID 0000-0002-2608-5589
Marc LecuitBiology of Infection Unit, Institut Pasteur, 75015 Paris, France.ORCID 0000-0002-4491-1063
Pierre-Marie LledoPerception and Memory Unit, Institut Pasteur, CNRS UMR3571, 75015 Paris, France. pmlledo@pasteur.fr.ORCID 0000-0002-8156-7003
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FRInserm · FRGroupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale · FRHôpital Lariboisière · FRHôpital Necker-Enfants Malades · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whereas recent investigations have revealed viral, inflammatory, and vascular factors involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lung pathogenesis, the pathophysiology of neurological disorders in coronavirus disease 2019 (COVID-19) remains poorly understood. Olfactory and taste dysfunction are common in COVID-19, especially in mildly symptomatic patients. Here, we conducted a virologic, molecular, and cellular study of the olfactory neuroepithelium of seven patients with COVID-19 presenting with acute loss of smell. We report evidence that the olfactory neuroepithelium is a major site of SARS-CoV2 infection with multiple cell types, including olfactory sensory neurons, support cells, and immune cells, becoming infected. SARS-CoV-2 replication in the olfactory neuroepithelium was associated with local inflammation. Furthermore, we showed that SARS-CoV-2 induced acute anosmia and ageusia in golden Syrian hamsters, lasting as long as the virus remained in the olfactory epithelium and the olfactory bulb. Last, olfactory mucosa sampling from patients showing long-term persistence of COVID-19-associated anosmia revealed the presence of virus transcripts and of SARS-CoV-2-infected cells, together with protracted inflammation. SARS-CoV-2 persistence and associated inflammation in the olfactory neuroepithelium may account for prolonged or relapsing symptoms of COVID-19, such as loss of smell, which should be considered for optimal medical management of this disease.

Indexed as

COVID-19AnimalsAnosmiaBrainCricetinaeHumansInflammationOlfactory MucosaRNA, ViralSARS-CoV-2RNA, Viral

Identifiers

PMID33941622
PMCPMC8158965
OpenAlexW3157383433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.